Cell Culture Technology– category –
-
Lonza and Entropic Unveil Scalable 96-Well 3D Human Skin Organoid Platform for Accelerated Screening
Scientist.com Switzerland Overview Lonza and Entropic have jointly developed a scalable 96-well 3D human skin organoid model, dramatically improving the efficiency of skin barrier function and injury screening. Utilizing Entropic's ZYRAL... -
ABM Unveils Spheroid & Organoid Medium Portfolio to Revolutionize 3D Culture Workflows for Drug Discovery and Disease Modeling
ABM (via Facebook) International Overview ABM has launched a new Spheroid & Organoid Medium portfolio designed to robustly support reproducible and scalable 3D culture workflows for drug discovery and disease modeling. This new produ... -
The Bioreactor Scaling Conundrum: Navigating Flexibility, Yield, and Design Trade-offs in Biopharmaceutical Manufacturing
Nature Partnerships International Overview Scaling bioprocess production in bioreactors presents a formidable challenge, characterized by inherent trade-offs between flexibility, cell yield, and process design. Bioreactor specifications ... -
TScan Therapeutics Pivots to In Vivo TCR-T Therapy, Halting Allogeneic Cell Program TSC-101 Amidst Manufacturing Challenges
FirstWord Pharma USA Overview TScan Therapeutics announced a strategic pivot, discontinuing its lead allogeneic cell therapy program, TSC-101, and shifting focus to preclinical in vivo TCR-T candidates for solid tumors, citing funding co... -
Angiogenic Tumor Organoids Revolutionize Model Design in Cell Therapy Development, RegMedNet Reports Critical Importance
RegMedNet UK Overview RegMedNet reports on the critical role of model design in cell therapy development, highlighting how the emergence of angiogenic tumor organoids is revolutionizing research. These advanced organoids enable researche... -
Northway Biotech Opens €61M Cell Therapy and Personalized Medicine CDMO in Vilnius, Marking Baltic Region’s First
PR Newswire Lithuania Overview Northway Biotech has launched a pioneering €61 million ($65M USD) cell therapy and personalized medicine CDMO facility in Vilnius, Lithuania, establishing the first such hub in the Baltics. This 3,500-squar... -
Pectin-GPTMS Biomaterial Enables Sustainable 3D Bioprinting Scaffolds for Tissue Engineering, ACS Publications Reports
ACS Publications USA Overview ACS Publications announces the development of a novel pectin-GPTMS-based biomaterial as a promising platform for the sustainable manufacturing of 3D bioprinting scaffolds in tissue engineering. This research... -
Evonik Invests $108M in Vancouver GMP Facility, Significantly Expanding Lipid-Based Drug Delivery Manufacturing Capacity
Contract Pharma USA Overview Evonik has announced a significant investment of $108 million into its GMP formulation manufacturing facility in Vancouver, Canada, dedicated to lipid-based drug delivery. This substantial capital injection a... -
Functional Polymer FP003B Maximizes Cell Yield in Microcarrier MSC Culture by Suppressing Aggregation, Frontiers Reports Breakthrough
Frontiers Switzerland Overview A new study in Frontiers proposes a breakthrough method using functional polymer 003B (FP003B) to significantly inhibit excessive aggregation of microcarriers/mesenchymal stromal cells (MSCs) and enhance ce... -
AI and Organ-on-Chip Systems Accelerate Therapeutic Discovery for Emerging and Re-Emerging Infections, Frontiers Review Highlights
Frontiers Switzerland Overview A Frontiers review highlights the groundbreaking potential of human organoids and organ-on-chip systems as AI-guided therapeutic discovery platforms for emerging and re-emerging infections. These platforms ...
